AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2013
Mar 12, 2013
29755_dirs_2013-03-12_e7f82d07-51d7-412c-8810-dc59ccff478a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-03-11
Reporting Person: RAPP EDWARD J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-11 | Common stock, $0.01 par value | P | 1200 | $37.67 | Acquired | 1200 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 200 | $37.6644 | Acquired | 1400 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 100 | $37.6611 | Acquired | 1500 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 100 | $37.66 | Acquired | 1600 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 100 | $37.6648 | Acquired | 1700 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 100 | $37.6654 | Acquired | 1800 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 100 | $37.6638 | Acquired | 1900 | Direct |
| 2013-03-11 | Common stock, $0.01 par value | P | 600 | $37.667 | Acquired | 2500 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4